More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Obesity significantly reduced the effectiveness of febuxostat-based urate-lowering therapy among men with gout, a recent ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...

Obesity in girls rose to 7.7% in 2022 from 0.6% in 1990. “Obesity has become a major public health issue in China, ranking as the sixth leading risk factor for death and disability in the ...

In recent years, China has consistently strengthened the top-level design of green and low-carbon development. A series of ...

SurilyGoelturnsheadsinagorgeousredsareeatAadarJainAlekhaAdvanisMehndi ...

New Delhi, Feb. 20 -- During his speech at the FII Priority Summit, US President Donald Trump chronicled his trip to Iraq, giving out never-heard before details of the visit to audience members. He ...

Still recovering from heavy spending during the pandemic, hospitals are squeezed by a slumping economy and government efforts ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

With the U.S. withdrawing from the World Health Organization and rethinking foreign aid, China has an opportunity to play a ...